Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$552M |
| 2 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$519M |
| 3 |
Microsoft
MSFT
|
+$417M |
| 4 |
Apple
AAPL
|
+$376M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$304M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$1.4B |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$396M |
| 3 |
Estee Lauder
EL
|
+$326M |
| 4 |
TSG
The Stars Group Inc.
TSG
|
+$302M |
| 5 |
S&P Global
SPGI
|
+$283M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.93% |
| 2 | Financials | 5.77% |
| 3 | Consumer Discretionary | 5.25% |
| 4 | Healthcare | 5.08% |
| 5 | Communication Services | 4.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4726
Pennant Group
PNTG
$1.4B
| $269K | ﹤0.01% |
11,923
-2,688
| -18% | -$56.3K |
|
4727
PUT
ICICI Bank
IBN
$108B
| $268K | ﹤0.01% |
28,800
-42,500
| -60% | -$377K |
|
4728
National Healthcare
NHC
$3.53B
| $268K | ﹤0.01% |
4,225
-1,712
| -29% | -$115K |
|
4729
CALL
Agios Pharmaceuticals
AGIO
$1.79B
| $267K | ﹤0.01% |
5,000
-2,800
| -36% | -$130K |
|
4730
Bloom Energy
BE
$60.6B
| $267K | ﹤0.01% |
24,542
+7,553
| +44% | +$59K |
|
4731
iShares US Healthcare Providers ETF
IHF
$1.21B
| $267K | ﹤0.01% |
6,910
+505
| +8% | +$19K |
|
4732
iShares MSCI Global Min Vol Factor ETF
ACWV
$3.32B
| $266K | ﹤0.01% |
3,037
| – | – |
|
4733
PUT
Harmony Gold Mining
HMY
$9.84B
| $266K | ﹤0.01% |
63,700
-11,900
| -16% | -$39.2K |
|
4734
BlackRock MuniYield Quality Fund III
MYI
$709M
| $266K | ﹤0.01% |
20,459
+2,781
| +16% | +$34.9K |
|
|
SRDX
4735
DELISTED
Surmodics
SRDX
| $266K | ﹤0.01% |
6,144
+2,078
| +51% | +$78.7K |
|
4736
WisdomTree
WT
$2.96B
| $266K | ﹤0.01% |
76,911
+18,508
| +32% | +$56.2K |
|
|
DVAX
4737
CALL
DELISTED
Dynavax Technologies
DVAX
| $265K | ﹤0.01% |
29,900
+9,600
| +47% | +$48.5K |
|
4738
IMAX
IMAX
$2.62B
| $265K | ﹤0.01% |
23,650
-14,107
| -37% | -$165K |
|
4739
Vanguard Morningstar Mega Cap Value ETF
MGV
$13.2B
| $265K | ﹤0.01% |
3,616
-3,600
| -50% | -$261K |
|
4740
Invesco S&P Ultra Dividend Revenue ETF
RDIV
$1.38B
| $265K | ﹤0.01% |
9,618
-1,703
| -15% | -$45K |
|
4741
Eldorado Gold
EGO
$7.87B
| $264K | ﹤0.01% |
+27,520
| New | +$239K |
|
|
FINV
4742
FinVolution Group
FINV
$1.15B
| $264K | ﹤0.01% |
146,000
-280,358
| -66% | -$467K |
|
4743
CALL
State Street SPDR EURO STOXX 50 ETF
FEZ
$4.42B
| $263K | ﹤0.01% |
7,400
-11,700
| -61% | -$378K |
|
|
CBPO
4744
DELISTED
China Biologic Products Holdings, Inc.
CBPO
| $263K | ﹤0.01% |
2,571
-1,422
| -36% | -$152K |
|
4745
DNP Select Income Fund
DNP
$4.05B
| $262K | ﹤0.01% |
24,060
+3,490
| +17% | +$37.5K |
|
4746
iShares MSCI Europe Financials ETF
EUFN
$4.14B
| $262K | ﹤0.01% |
18,385
+9,033
| +97% | +$119K |
|
4747
PUT
Southern Copper
SCCO
$143B
| $262K | ﹤0.01% |
7,120
-7,227
| -50% | -$229K |
|
|
TEI
4748
Templeton Emerging Markets Income Fund
TEI
$314M
| $262K | ﹤0.01% |
33,427
+238
| +0.7% | +$1.81K |
|
4749
CALL
BorgWarner
BWA
$13.1B
| $261K | ﹤0.01% |
8,406
-7,157
| -46% | -$189K |
|
|
GOOD
4750
Gladstone Commercial Corp
GOOD
$605M
| $261K | ﹤0.01% |
13,895
-372
| -3% | -$6.1K |
|
Similar funds
Citigroup's Q2 2020 Portfolio in Review
As of Q2 2020, Citigroup held 7,909 positions worth $128B, up 16% from $111B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Citigroup withdrew a net $7.44B in Q2 2020, closing 313 positions and reducing 3,200 holdings. Its most notable exit was Allergan plc, an estimated $1.4B position sold in full.
By sector, the portfolio is most concentrated in Technology at 8.9% of assets, up from 6.7% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Citigroup opened a new position in Invesco Dorsey Wright Technology Momentum ETF worth $156M.
- Citigroup's largest Q2 2020 buy was Invesco Dorsey Wright Technology Momentum ETF: 4,800,363 shares worth $156M.
- Citigroup added most to iShares iBoxx $ Investment Grade Corporate Bond ETF in Q2 2020, an estimated $552M increase.
- Citigroup's biggest Q2 2020 reduction was Alphabet (Google) Class A, cutting an estimated $396M.
- Citigroup fully exited Allergan plc in Q2 2020, selling an estimated $1.4B.
- Citigroup's ten largest holdings make up 23% of its $128B portfolio in Q2 2020.
- Citigroup opened 257 new positions and closed 313 in Q2 2020.
- Citigroup's portfolio value rose 16% quarter-over-quarter to $128B.
Based on Citigroup's 13F filing for Q2 2020, filed 12 Aug 2020.